Campbell Rogers, Chief Medical Officer at HeartFlow, Inc. (HTFL +3.66%), executed a sale of 9,219 shares on August 17, 2026, totaling approximately $380,100 according to the SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold | 9,219 |
| Transaction value | $380,100 |
| Post-transaction shares (total) | 231,999 |
| Post-transaction shares (directly held) | 86,459 |
| Post-transaction shares (indirectly held) | 145,540 |
| Post-transaction value | $9.73 million |
Transaction value based on SEC Form 4 weighted average sale price ($41.23); post-transaction value based on August 17, 2026 market close ($41.94).
Key questions
- What initiated this disposal of equity?
The transaction was part of a Rule 10b5-1 trading plan adopted on December 12, 2025, which allows insiders to execute…
